Re: Efficacy and Safety of Tadalafil 5mg Once Daily in the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia in Men Aged ≥75 years: Integrated Analyses of Pooled Data from Multinational, Randomized, Placebo-controlled Clinical Studies.
Urology Department, Kaiser-Franz-Josef Hospital, Vienna, Austria. Electronic address: stephan.madersbacher@wienkav.at.
Stephan
S
Madersbacher
D000368:Aged; D002243:Carbolines; D004311:Double-Blind Method; D006801:Humans; D059411:Lower Urinary Tract Symptoms; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors; D011470:Prostatic Hyperplasia; D000068581:Tadalafil; D016896:Treatment Outcome
D002243:Carbolines; D058986:Phosphodiesterase 5 Inhibitors; D000068581:Tadalafil